HC Deb 24 July 1996 vol 282 cc523-4W
Mr. Thomason

To ask the Secretary of State for Health if he will list the membership of the Administration of Radioactive Substances Advisory Committee. [40009]

Mr. Horam

The committee is chaired by Professor James McKillop, Muirhead Professor of Medicine at the University Department of Medicine, Glasgow. The 19 members are:

  • Dr. Paul Abram, N. Ireland Centre for Clinical Oncology, Belfast (Clinical Oncology);
  • Dr. Muriel Buxton-Thomas, King's College Hospital, London (Nuclear Medicine);
  • Dr. Helen Carty, Royal Liverpool Children's Hospital (Clinical Radiology);
  • Dr. Susan Clarke, Guy's and St. Thomas' Hospital, London (Nuclear Medicine);
  • Dr. Tony Coakley, Kent and Canterbury Hospital (Nuclear Medicine);
  • Dr. Malcolm Frier, University Hospital, Nottingham (Radiopharmacy);
  • Dr. Chris Gibson, Glan Clwyd Hospital, Rhyll (Physics);
  • Dr. Gerry Gillen, Stobhill Hospital, Glasgow (Physics);
  • Dr. Michael Henk, Royal Marsden Hospital, London (Clinical Oncology);
  • Dr. Stuart Hesselwood, City Hospital, Birmingham (Radiopharmacy);
  • Dr. Stephen Mather, St. Bartholomew's Hospital, London (Radiopharmacy);
  • Professor Ralph McCready, Royal Marsden Hospital, Sutton (Nuclear Medicine);
  • Dr. Peter Mountford, Royal Infirmary, Stoke on Trent (Physics);
  • Dr. Tom Nunan, Guy's and St. Thomas' Hospital, London (Nuclear Medicine);
  • 524
  • Dr. Mary Prescott, Manchester Royal Infirmary (Nuclear Medicine);
  • Dr. John Stather, National Radiological Protection Board (Radiobiology);
  • Dr. Wendy Tindale, Royal Hallamshire Hospital, Sheffield (Physics);
  • Dr. Derek Waller, Southampton General Hospital (Clinical Pharmacology);
  • Mr. John Watkinson, Queen Elizabeth Hospital, Birmingham (Surgery).